RxDoctor Payments Data

Robert Cullen

Physician Assistant · Coeur D Alene, IDNPI 1366110223

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $7,377 of the $11,076 with a category attached, or 66.6%. 8 manufacturers reported payments, led by Sanofi at 47.6% of the total. 2025 is the largest year on record at $8,815, more than ten times the $162 reported in 2023. Among physician assistant clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,076in general payments, 2019–2025

Across 53 payments — averaging $208.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$5K
  • TG Therapeutics, Inc.$3K
  • Genentech USA, Inc.$1K
  • EMD Serono, Inc.$787
  • Bristol Myers Squibb$277
  • AstraZeneca$155
  • plus $112 from 2 others

What the payments were for

  • Consulting fees$7,37767%
  • Speaking & faculty fees$2252%
  • Travel & lodging$9108%
  • Food & beverage$2,44822%
  • Education$1161%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,076 in reported general payments places this provider in the 95th percentile of 1,027 physician assistant providers in Idaho.

See all physician assistant providers in Idaho

Medicare billing

Part B allowed, 2024
$23,019
Medicare patients
113
Services billed
413

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Kesimpta PenOfatumumab67$595,629
Dalfampridine ErDalfampridine50$24,478
GemtesaVibegron27$18,518
NuedextaDextromethorphan Hbr/Quinidine11$15,382
UbrelvyUbrogepant14$15,033
MyrbetriqMirabegron18$11,517
Lacosamide26$2,710
Modafinil18$1,807
Gabapentin48$1,309
Pregabalin50$1,087
Baclofen32$994
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine30$851
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine15$769
Methylphenidate ErMethylphenidate Hcl11$526
RizatriptanRizatriptan Benzoate13$494

Paid to pharmacies, not to this prescriber.

Other physician assistant in Coeur D Alene

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →